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Objective: To evaluate the antibacterial activity of methanol extract of Hibiscus sab-
dariffa (H. sabdariffa) calyces employed in Sudanese folk medicine against ﬁve hospital
isolates of multidrug resistant Acinetobacter baumannii (MDR A. baumannii).
Methods: The antibacterial activity of 80% methanol extract (v/v) of H. sabdariffa
calyces was evaluated by agar disc diffusion, minimum inhibitory concentration and
minimum bactericidal concentration methods. Antibiotic susceptibility of selected
A. baumannii strains was tested.
Results: In the present investigation, the methanol extract from the calyces of
H. sabdariffa exhibited signiﬁcant antibacterial properties against the non-MDR
A. baumannii as well as the MDR A. baumannii strains with a zone of inhibition
ranging from (11.3 ± 0.3) to (13.6 ± 0.3) mm. The relative percentage inhibition of
H. sabdariffa extract (10 mg/disc) with respect to gentamicin (10 mg/disc) had potent
antibacterial properties and was much more effective than gentamicin. Values of mini-
mum inhibitory concentration and minimum bactericidal concentration ranged from 25 to
50 and 50 to 100 mg/mL, respectively, revealing the potential bactericidal properties of
the extract.
Conclusions: According to the present study, the calyces of H. sabdariffa can be used as
a substitute source of the current ineffective synthetic antibiotics used against MDR
A. baumannii.1. Introduction
In the 21st century, the infectious diseases remain the leading
cause of death classiﬁed by the World Health Organization,
where around 15 million people (accounting for >25% annual
world death) die every year from infectious diseases world-
wide[1]. Antibiotics, the most effective drugs against microbial
infections in the 1950s, are recently losing their efﬁcacies as
most microorganisms have an acquired resistance[2]. Despite
the negative side effects of antibiotics on human organs, the
intensive use of antibiotics has led to emerging of what is
called multidrug resistant (MDR) bacteria which are nowraising remarkably all over the world and become an
international public health threat[3]. Moreover, such pathogens
have negative impacts on economy that infections have costed
the United States 21–34 billion dollars annually[4].
Acinetobacter baumannii (A. baumannii) is a short Gram-
negative plump rod (coccobacilli) belonging to genus Acineto-
bacter. It was earlier believed that this bacterium is ubiquitous in
nature. But recently, it emerged as one of the most dangerous
nosocomial pathogens worldwide, since it showed resistance to
all known antibiotics[5]. A. baumannii can frequently cause
pneumonia, bacteraemia, meningitis, wound infections and
urinary tract infections[6]. The MDR A. baumannii is deﬁned
as resistants to more than two antibiotics classes, especially
ampicillin-sulbactam, ﬂuoroquinolones (ciproﬂoxacin or levo-
ﬂoxacin), aminoglycosides (gentamicin, tobramycin or amika-
cin), antipseudomonal cephalosporins (ceftazidime or cefepime)
and antipseudomonal carbapenems (imipenem or meropenem)[5].
MDR A. baumannii is widely prevalent which has been reported
and isolated from hospitals in many countries and areas, such as
India, Turkey, Taiwan, Argentina, Korea, Japan, Iran, Saudihis is an open access article under the CC BY-NC-
Table 1








Emad Mohamed Abdallah/Journal of Acute Disease 2016; 5(6): 512–516 513Arabia, Latin America, North America, Europe, Asia–Paciﬁc,
Brazil, Australia, Spain, US and UK[7].
Plants are the main source of medications for human, since
they appear on earth and have abilities to synthesize endless
secondary metabolites known as phytochemical compounds
which serve as plant defense mechanism against macro and
micro-organisms[8]. Alkaloids, ﬂavonoids, phenolics and tannins
are among the most important phytochemicals used in
phytotherapy[9]. The World Health Organization estimated that,
during the past decade, a large proportion of the population
depended on traditional medicinal plants for treatment of
different illnesses and preferred the modern medication, and
even in developed countries, many people have begun to use
medicinal plants as an alternative therapy[10]. Therefore, it is a
logical approach to search for new antibacterial agents from
natural sources like plants, since most of the recent drugs are
initially obtained or semi-synthesized from these sources,
particularly from those which are prescribed in traditional
medicine[11]. Numerous studies are published showing a potent
antibacterial activity of many medicinal plants[8]. However,
little is known about the antibacterial activity of plants against
MDR A. baumannii.
Roselle [Hibiscus sabdariffa L. (H. sabdariffa)] is a well
known multipurpose medicinal plant, which belongs to family
Malvaceae. It is an annual tropical short shrub and distributed in
many tropical and sub-tropical regions in the world[12]. It is used
traditionally for many purposes, such as hot and cold beverage,
ﬂavoring agent, food industry and traded as herbal medicine[13].
It also holds a plentiful potential of phytochemical compounds
and has antioxidant, hypotensive, hypocholesterolemic,
immune-modulated, hepatoprotective, renoprotective, diuretic,
anti-obesity, antiurolithic, antidiabetic, antimicrobial and anti-
cancer properties without any signiﬁcant genotoxic effects[14].
Calyces of roselle is a famous public beverage in Sudan
employed traditionally for the treatment of many ailments,
such as respiratory tract infections, colds, fevers, hypertensions
and malaria[15]. The previous study showed that it has
signiﬁcant antibacterial activity against Staphylococcus aureus,
Staphylococcus epidermidis, Salmonella enterica, Klebsiella
pneumonia, Pseudomonas aeruginosa, Escherichia coli,
Proteus vulgaris and Bacillus cereus, etc.[16]. The aim of the
present study is to evaluate the antibacterial activity of the
Sudanese roselle calyces (H. sabdariffa) against some hospital
isolates of MDR A. baumannii.
2. Materials and methods
2.1. Plant material and extraction
The dried ﬂowers of H. sabdariffa were purchased from local
herbal markets in 2015 from Khartoum, Sudan. The plant ma-
terials were taxonomically identiﬁed by a botanist at College of
Sciences and Arts, Al-Rass, Qassim University. Voucher sample
specimen was deposited. Calyces of H. sabdariffa were separated
from the dried ﬂowers and ground to a ﬁne powder. About 100 g
dried powder was taken and put in a sterile dark glass container
and 500 mL of 80% v/v methanol (Sigma–Aldrich, St. Louis,
USA) was loaded gradually into the container, soaked and sub-
jected to frequent shaking and macerated for 3 days at room
temperature [(37 ± 2) C] in a dark cabinet. Then, the suspension
was ﬁltered using Whatman ﬁlter paper No. 1 (Sigma–Aldrich,
St. Louis, USA). The methanolic ﬁltrate was allowed toevaporate in the incubator (BINDER GmbH, Neckarsulm, Ger-
many) at 45 C for up to 10 days till a sticky extract obtained.
Several hours before the antibacterial testing, 1 g of the extract
was reconstituted in 2 mL of absolute methanol to get 500 mg/
mL[16].
2.2. Isolation and identiﬁcation of bacteria and
antibiotic sensitivity test
A. baumannii was isolated from different clinical samples
like pus, wound and sputum by Dr. Fiaz Ahmed (pathologist)
from Department of Pathology and Laboratory Medicine, Al-
Rass General Hospital (Table 1). The samples were identiﬁed
by subculturing onto blood agar and MacConkey agar for 24 h at
37 C. The growing colonies were examined with Gram-
staining, which were Gram-negative coccobacilli under the mi-
croscope conﬁrmed as A. baumannii by further biochemical tests
and then classiﬁed as either MDR or non-MDR strain by the
antibiotics susceptibility testing according to Kirby–Bauer disk
diffusion method recommended by Clinical and Laboratory
Standards Institute guidelines[17]. A. baumannii isolates were
tested against the following antibiotics: amikacin (30 mg/disc),
ceftazidime (30 mg/disc), aztreonam (30 mg/disc), piperacillin
(100 mg/disc), imipenem (10 mg/disc), ciproﬂoxacin (5 mg/
disc) and cefotaxime (30 mg/disc) purchased from Oxoid
Limited, Basingstoke, UK. Isolates showing resistance to at
least three antibiotics were considered as MDR A. baumannii.
2.3. Antibacterial assay
The modiﬁed Kirby–Bauer disc diffusion method was used to
evaluate the antibacterial activity of theHibiscus extract[16]. Prior to
the experiment, A. baumannii strains were subcultured in nutrient
broth (Watin–Biolife, Riyadh, Saudi Arabia) and incubated for
18 h at 37 C in order to reach the exponential phase, then
adjusted by adding normal saline to be equivalent to 0.5
McFarland standard, which comprised 1.0 × 108 CFU/mL.
About 100 mL from each adjusted strain was loaded separately
in 90 mm sterile disposable Petri dishes (Jalil Medicals,
Manama, Bahrain), and 20 mL sterile warm Mueller–Hinton
agar (Watin–Biolife, Riyadh, Saudi Arabia) was poured into
each plate and left until solidiﬁed at room temperature (35–
37 C). About 6 mm blank discs were cut off from Whatman
ﬁlter paper No. 1 and autoclaved. Then, 20 mL H. sabdariffa
methanol extract at a concentration of 500 mg/mL (10 mg/disc)
was loaded to the sterile disc and put over the seeded Mueller–
Hinton agar plate. About 10 mg/disc gentamicin (Oxoid Limited,
Basingstoke, UK) served as a positive control and 6 mm disc
saturated with methanol served as negative control, which were
also loaded. The plate was incubated for 24 h at 37 C. The
experiment was repeated thrice and the mean zone of inhibition
around the discs was recorded.
Table 2




AK CAZ ATM PRL IMI CIP CTX
Ab1 S S S S S S S
Ab2 R R R R S R R
Ab3 R R R S S R R
Ab4 R R R R S R R
Ab5 S R R R S R R
S: Sensitive; R: Resistant; AK: Amikacin; CAZ: Ceftazidime; ATM:
Aztreonam; PRL: Piperacillin; IMI: Imipenem; CIP: Ciproﬂoxacin;
CTX: Cefotaxime.
Table 3
Antibacterial activity of the methanol extract of H. sabdariffa against
different strains of A. baumannii compared to gentamicin.
Treatments Mean zone of inhibition of A. baumannii (mm)




11.3 ± 0.3 13.6 ± 0.3 11.6 ± 0.3 13.3 ± 0.3 13.3 ± 0.3
Gentamicin
(10 mg/mL)
22.5 ± 0.2 9.1 ± 0.2 0.0 ± 0.0 9.6 ± 0.2 11.6 ± 0.2
Table 4
MIC, MBC and MBC/MIC rations of calyces of the methanol extract of
H. sabdariffa against different A. baumannii strains.
Bacterial strains Methanol extract of H. sabdariffa (mg/mL)
MIC MBC MBC/MIC
Ab1 50 50 1
Ab2 25 50 2
Ab3 25 50 2
Ab4 25 50 2
Ab5 50 100 2
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(RPI)
RPI of H. sabdariffa methanol extract (10 mg/disc) and the
methanol (20 mL/disc) as a negative control, with respect to
gentamicin (10 mg/disc) as a positive control against MDR
A. baumannii were calculated using the following formula[18].
RPI ð%Þ = 100 × ðX−YÞ
Z −Y
where X is total area of inhibition of the tested extract, Y is total
area of inhibition of the solvent, Z is total area of inhibition of
the antibiotic.
The total area of the inhibition was calculated according to
the following equation:
Area =pr2
where r is radius of the zone of inhibition, p = 3.14.
2.5. Determination of minimum inhibitory concentration
(MIC) and minimum bactericidal concentration (MBC)
MIC of the calyces of H. sabdariffa methanol extract against
MDR A. baumannii strains which showed sensitivity towards
the extract was estimated by adding 1.0 mL of the methanol
extract at a concentration of 400 mg/mL to a tube containing
1.0 mL Mueller–Hinton broth (Watin–Biolife, Riyadh, Saudi
Arabia). Then, two-fold serial dilutions were used to get the
concentrations 400, 200, 100, 50, 25, 12.5 and 6.25 mg/mL.
While a tube containing 1.0 mL sterile distilled water and
1.0 mL broth was served as positive control. All tubes were
seeded with 10 mL tested bacterial strains adjusted to 0.5 Mac-
Farland. Another tube containing only 1.0 mL absolute methanol
and 1.0 mL broth was used as negative control. All tubes were
incubated for 18 h at 37 C. After incubation, the tube of the
least concentration of H. sabdariffa methanol extract that did not
show any visible growth was considered as MIC[19].
MBC of the calyces of H. sabdariffa methanol extract against
MDR A. baumannii strains were evaluated as the following:
100 mL from each of the MIC tubes that did not show any
growth was subcultured on Mueller–Hinton agar plates and
incubated at 37 C for 24 h and inspected after incubation for
growth. The least concentration that showed no single colony of
bacteria was taken as MBC[20].
2.6. Statistical analysis
Data were analyzed using the statistical package program
SPSS 15.0. The experiments were repeated thrice. Values were
expressed as mean ± SEM and P < 0.05 was considered as
statistically signiﬁcant. One-way ANOVA was carried out by
Tukey honestly signiﬁcant difference test.
3. Results
As shown in Table 2, non-MDR A. baumannii strain (Ab1)
was susceptible to all tested antibiotics. Ab2 and Ab4 strains were
resistant to six types of antibiotics and sensitive only to imipenem
(10 mg/disc). Ab3 strain was resistant to ﬁve types of antibiotics
and sensitive to piperacillin (100 mg/disc) and imipenem (10 mg/
disc). Ab5 strain was resistant to ﬁve types of antibiotics andsensitive to amikacin (30mg/disc) and imipenem (10mg/disc). The
antibacterial activity of the SudaneseH. sabdariffa calyces against
the above-mentioned hospital isolates of A. baumannii has been
evaluated in the present research work. The results revealed that
the tested extract exhibited signiﬁcant antibacterial activity
against these pathogens. Table 3 shows the mean zone of inhibi-
tion of A. baumannii strains (Ab1–Ab5). The non-MDR
A. baumannii (Ab1) showed sensitivity against the extract
(11.3 ± 0.3) mm, but still less than gentamicin (22.5 ± 0.2) mm.
Interestingly, other MDR A. baumannii strains (Ab2–Ab5)
revealed signiﬁcant sensitivity to the extract and were higher than
gentamicin, particularly Ab3 which was totally resistant to
gentamicin (0.0 ± 0.0) and sensitive to the extract. RPI of the
methanol extract of H. sabdariffa calyces with respect to genta-
micin was obtained. The methanol extract of the calyces of
H. sabdariffa showed the maximum RPI against A. baumannii
strain (Ab2) which was 223.3%, followed by Ab4 (191.8%), Ab5
(131.4%) and Ab1 (63.5%). The A. baumannii strain (Ab3) was
omitted, since the effect of gentamicin on it was zero. The anti-
bacterial efﬁcacy of the calyces of H. sabdariffa was also evalu-
ated using MIC and MBC assays (Table 4). The results showed
that the MIC values ranged between 25 and 50 mg/mL, while the
MBC values ranged between 50 and 100 mg/mL with MBC/MIC
ratio between 1 and 2.
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In the present study, the Acinetobacter strains used in this
investigation were four representing MDRs and one representing
non-MDR in order to compare the susceptibility of these mi-
croorganisms towards the tested plant extract of H. sabdariffa.
As shown in Table 2, most of the tested strains revealed resis-
tance against many antibiotics. Most of these seven antibiotics
were recently launched, which revealed that A. baumannii is a
highly virulent pathogen and able to acquire resistance rapidly
against antibiotics. This observation was in agreement with
Lowings et al.[21] who stated that A. baumannii evolves
resistance to all known antibiotics and has rapid developing
mechanisms and no effective treatment options seen in the
near future. As represented in Table 3, the MDR A. baumannii
strains (Ab2–Ab5) showed signiﬁcant sensitivity to the meth-
anol extract of H. sabdariffa and were higher than gentamicin.
That is, the methanol extract of the H. sabdariffa calyces has
potent antibacterial activity against MDR A. baumannii. It was
previously reported that calyces of H. sabdariffa have antibac-
terial properties against different pathogens, foodborne patho-
gens, methicillin-resistant Staphylococcus aureus, Klebsiella
pneumoniae, Pseudomonas aeruginosa and A. baumannii[16,22,23].
These potent antibacterial properties of the calyces of
H. sabdariffa could be attributed to its richness in secondary
phytochemical metabolites. The previous study on Sudanese
roselle revealed the presence of alkaloids, phenolic
compounds, ﬂavonoids and saponins[16]. These compounds are
considered to be the major groups of antimicrobial compounds
in plants[24].
The results of the antibacterial activity of the extract were
compared with the positive control (gentamicin) for evaluating
their RPI, which indicated that calyces of H. sabdariffa have
potent antibacterial properties and are much effective than
gentamicin. Recently, A. baumannii strains were reported
developed high resistance to gentamicin[25]. Table 4 represents
MIC, MBC and MBC/MIC rations of calyces of the
H. sabdariffa methanol extract against different A. baumannii
strains. The extract is considered to be bactericidal when the
ratio of MBC/MIC 4, while considered bacteriostatic when
MBC/MIC >4[26]. Accordingly, the calyces of H. sabdariffa
possess effective bacteriocidal activity against all tested strains
of A. baumannii. These ﬁndings are in agreement with Liu
et al.[23] who mentioned that, based on MIC values,
A. baumannii was inhibited effectively. Several previous
studies on medicinal plants were reported antibacterial activity
against MDR clinical strains of A. baumannii including
Magnolia ofﬁcinalis, Mahonia bealei, Rabdosia rubescens,
Rosa rugosa, Rubus chingii, Scutellaria baicalensis and
Terminalia chebula[27]. Accordingly, ﬁndings from the present
study showed that the crude extract (80% methanol) of the
calyces of H. sabdariffa exhibited potent antibacterial activity
against MDR strains of A. baumannii competitor to antibiotics
and this activity tended to be bactericidal. Further future
studies are recommended for the fraction the compound(s)
responsible for their antibacterial activity in addition to other
pharmacological studies, which may lead to the discovery of
new natural antibiotic from roselle.
Given the lack of new antibiotics and the spread of MDR
A. baumannii, there will be an essential need for new antibac-
terial drugs with a different mode of action. This study suggested
that Sudanese roselle calyces (H. sabdariffa) possess potentantibacterial properties against MDR A. baumannii which could
be used as an antibacterial drug. It is worthy for the research
scholars and pharmaceutical companies to carry out further in-
vestigations on natural products and medicinal plants for isola-
tion and identiﬁcation of new antibacterial compounds which
can be formulated as effective antibiotics.
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